Perineal block with prilocaine during labour: effect on the newborn infant. A pilot study.

Perineal block with prilocaine during labour: effect on the newborn infant. A pilot study. - Prilocaine pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30974

Enrollment

200

Registered

2007-07-17

Start date

2007-05-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemiglobinemia

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: All women who will give birth in our hospital and consent in participating in our study and their newborn infants

Exclusion criteria

Exclusion criteria: Women with any form of hereditary methemoglobinemia. Women how are carriers or suffer from one or more of the following illnesses: G6PD deficiency or any form of hemoglobinopathy. Women who, at the time of labour, receive other drugs which can cause methemoglobinemia. Women who would want to use the umbilical cord blood for other purposes such as stem cell donation.

Design outcomes

Primary

Measure	Time frame
1. Foetomaternal distribution of prilocaine. This will be expressed as a ratio. 2. levels of methemoglobinemia in newborns after perineal block with prilocaine during labor (following the regimen used in our hospital) 3. Levels of methemoglobine in newborn infants which are not exposed to any drug which can cause methemoglobinemia	—

Secondary

Measure	Time frame
Clinical examination of the newborn infant	—

Countries

Netherlands

Outcome results